Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
NanoVibronix ( (NAOV) ) has provided an announcement.
On July 18, 2025, NanoVibronix, Inc. entered into a Securities Purchase Agreement with an institutional investor to sell Series H Convertible Preferred Stock and warrants, raising $8 million in gross proceeds. The company plans to use $5 million to redeem outstanding shares of its Series X Preferred Stock and the remainder for working capital. This agreement, which includes provisions for additional future investments, aims to strengthen NanoVibronix’s financial position and support its operational growth.
More about NanoVibronix
NanoVibronix, Inc. operates in the medical device industry, focusing on developing non-invasive, portable therapeutic ultrasound devices. The company’s primary products include devices designed to treat pain, wounds, and other medical conditions, with a market focus on enhancing patient care through innovative technology.
Average Trading Volume: 4,949,205
Technical Sentiment Signal: Sell
Current Market Cap: $2.61M
For detailed information about NAOV stock, go to TipRanks’ Stock Analysis page.